SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-001766
Filing Date
2022-01-12
Accepted
2022-01-12 16:49:37
Documents
13
Period of Report
2022-01-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea153921-8k_revelation.htm   iXBRL 8-K 61876
  Complete submission text file 0001213900-22-001766.txt   298189

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE revb-20220106.xsd EX-101.SCH 4189
3 XBRL DEFINITION FILE revb-20220106_def.xml EX-101.DEF 28001
4 XBRL LABEL FILE revb-20220106_lab.xml EX-101.LAB 38777
5 XBRL PRESENTATION FILE revb-20220106_pre.xml EX-101.PRE 26616
7 EXTRACTED XBRL INSTANCE DOCUMENT ea153921-8k_revelation_htm.xml XML 7307
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 22527047
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences